SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Trading Statement

4 May 2023 07:00

RNS Number : 3226Y
Pollen Street PLC
04 May 2023
 

FOR IMMEDIATE RELEASE

4 May 2023

 

 

Pollen Street plc Q1 Trading Update

Pollen Street plc ("Pollen Street" or the "Group") today issues its trading update for the period ended 31 March 2023.

Highlights

· Overall AUM remained at £3.4 billion with fundraising activity focussed on Private Equity V, which is progressing well

· Average Fee-Paying AuM[1] has continued to build to £2.5 billion for Q1 2023, up from £2.3 billion for 2022

· The Investment Company performance over Q1 2023 was particularly strong with a Net Investment Return[2] of 9.0 per cent per annum

· The tangible net asset value of the Group as of 31 March 2023 was £347 million, equivalent to £5.40 per share

· The Q1 2023 dividend has been announced at 16p per share in line with targets previously issued

Asset Manager

Pollen Street's focus over Q1 has been preparing for the final close of Credit III and the first close of Private Equity V. As such AuM[3] on an investor commitment basis has remained stable at £3.4 billion as of 31 March 2023.

Fee-Paying AuM tracks deployment in our credit funds, which is the basis that fees are charged. Average Fee-Paying AuM increased to £2.5 billion for Q1 2023. This is up from £2.3 billion for 2022, reflecting the momentum in deployment in the credit funds.

Investment Company

The Investment Company has continued its strong performance over Q1 2023, benefiting from the senior secured strategy, with minimal impairments and bad debts. The Net Investment Return was 9.0 per cent per annum for Q1 2023, up from 8.2 per cent per annum in H2 2022. The step-up was driven mainly by early repayment fees on one deal. The underlying Net Investment Return excluding the effect of this was 8.3 per cent. The capital returned was redeployed quickly with a net debt-to-equity ratio of 63 per cent at 31 March 2022, which is within the target range of 50 per cent to 75 per cent.

Net Asset Value

The net asset value of the Group as of 31 March 2023 was £578 million, which is equivalent to £9.00 per share. The tangible net asset value was £347 million, equivalent to £5.40 per share. 

 

About Pollen Street plc

Pollen Street is an alternative asset manager dedicated to investing with the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") and on-balance sheet investments (the "Investment Company").

The Investment Company portfolio is well-diversified and focused on senior asset-based direct lending investments. These investments target stable high-income returns together with strong capital preservation. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

POLN is listed on the London Stock Exchange (ticker symbol: POLN). Further details are available at www.pollencap.com.

 

For further information about this announcement please contact:

 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress / Dion Di Miceli

+44 (0)20 7623 2323

 

Liberum Capital Limited - Joint Broker

Chris Clarke / Edward Mansfield

+44 (0)20 3100 2000

 

FGS Global

Chris Sibbald

Chris.Sibbald@fgsglobal.com

+44 (0)7855955531

 

Link Company Matters Limited - Corporate Secretary

polncosec@linkgroup.co.uk 

 

 

ENDS


[1] Average Fee-Paying AuM is calculated as the average of the opening and closing investor commitments for active fee-paying Private Equity funds, invested cost for other fee-paying Private Equity funds, total assets for the on-balance sheet assets and net invested amount for fee-paying Private Credit funds

[2] Net Investment Asset Return is calculated as the ratio of the income from the Investment Company segment to the Net Investment Assets, expressed as a percentage

[3] AuM on an investor commitment basis is calculated as investor commitments for active Private Equity funds, invested cost for other Private Equity funds, total assets for the on-balance sheet assets and investor commitments for Private Credit funds

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEXLFBXELXBBE
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.